Quarry LP’s Beam Therapeutics BEAM Stock Holding History

Quarry LP’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$167K	Buy	7,000 +2,000	+40%	+$55.5K	0.03%	368
2025 Q4	$139K	Sell	5,000 -4,849	-49%	-$124K	0.02%	341
2025 Q3	$239K	Buy	9,849 +1,849	+23%	+$36.8K	0.05%	303
2025 Q2	$136K	Buy	8,000 +3,500	+78%	+$61K	0.03%	446
2025 Q1	$87.9K	Buy	4,500 +3,000	+200%	+$78.6K	0.02%	569
2024 Q4	$37.2K	Sell	1,500 -4,500	-75%	-$115K	0.01%	909
2024 Q3	$147K	Buy	6,000 +2,400	+67%	+$62K	0.04%	311
2024 Q2	$84.3K	Buy	3,600 +2,800	+350%	+$68.8K	0.02%	416
2024 Q1	$26.4K	Buy	+800	New	+$24.9K	0.01%	787

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Quarry LP's BEAM Position: Q1 2026 in Review

Quarry LP increased its Beam Therapeutics (BEAM) stake by 40% in Q1 2026, buying an estimated $55.5K and bringing the position to 7,000 shares worth $167K. The position accounts for 0.03% of the portfolio, ranked #368.

Quarry LP first reported a position in BEAM in Q1 2024 and has held it in 9 quarters since. The position peaked at $239K in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Quarry LP held 7,000 shares of Beam Therapeutics worth $167K as of Q1 2026.
Quarry LP bought 2,000 Beam Therapeutics shares in Q1 2026, an estimated $55.5K.
Beam Therapeutics made up 0.03% of Quarry LP's portfolio in Q1 2026, its #368 holding.
Quarry LP first reported a position in Beam Therapeutics in Q1 2024 and has held it in 9 quarters since.
Quarry LP's Beam Therapeutics position peaked at $239K in Q3 2025.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.